載入...

P04.12 The preclinical efficacy study using mesenchymal stem cells expressing TRAIL & CD for glioblastoma.

BACKGROUND: Our previous study using mesenchymal stem cells (MSCs) as delivery vehicles for tumor necrosis factor-related apoptosis inducing ligand (TRAIL) showed an anti-tumor effect in vitro and in vivo for glioblastoma. However, because most malignant glioma cells exhibit TRAIL resistance, we nee...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Ahn, S, Jeun, S
格式: Artigo
語言:Inglês
出版: Oxford University Press 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144671/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.246
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!